No

Corticosteroid, Topical

Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (medium potency topical corticosteroid)

C

Hypersensitivity to mometasone or any component; fungal, viral, or tubercular skin lesions, herpes simplex or zoster

Adverse systemic effects may occur when used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children

<1%: Acne, hypopigmentation, allergic dermatitis, maceration of the skin, skin atrophy, striae, miliaria, itching, folliculitis, hypertrichosis, HPA suppression, Cushing's syndrome, growth retardation, burning, irritation, dryness, secondary infection

No data reported

May depress the formation, release, and activity of endogenous chemical mediators of inflammation (kinins, histamine, liposomal enzymes, prostaglandins). Leukocytes and macrophages may have to be present for the initiation of responses mediated by the above substances. Inhibits the margination and subsequent cell migration to the area of injury, and also reverses the dilatation and increased vessel permeability in the area resulting in decreased access of cells to the sites of injury.

Adults: Topical: Apply sparingly to area once daily, do not use occlusive dressings. Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.

None reported

None reported

No information available to require special precautions

No effects or complications reported

Before applying, gently wash area to reduce risk of infection; apply a thin film to cleansed area and rub in gently and thoroughly until medication vanishes; avoid exposure to sunlight, severe sunburn may occur

For external use only; do not use on open wounds; should not be used in the presence of open or weeping lesions; use sparingly

Cream: 0.1% (15 g, 45 g)

Lotion: 0.1% (30 mL, 60 mL)

Ointment, topical: 0.1% (15 g, 45 g)